To study the medicinal effectiveness of Unani formulation â??Sharbat Toot Siyahâ?? in cases of Waram-i-Halaq (Pharyngitis)

Clinical Validation of Unani Pharmacopoeial formulation â??Sharbat Toot Siyahâ?? in cases of Waram-i-Halaq (Pharyngitis)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/10/006296

Enrollment

246

Registered

2015-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J029- Acute pharyngitis, unspecified Health Condition 2: null- Waram-i-Halaq (Pharyngitis)

Interventions

Intervention1: Sharbat Toot Siyah: 20 ml orally twice daily for one week Control Intervention1: NIL: NA

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group of 18-60 years. 2. Presence of all of the following signs and symptoms of Waram-i-Halaq (Pharyngitis): 1. Buhha al-Sawt (Hoarseness of Voice) 2. Surfa Yubsiyya (Dry Cough) 3. â??Usr al-Bal (Dysphagia) 4. HumÄ?ma Bulâ??Å«m (Pharyngeal Erythema 5. Wajaâ??e-halaq (Pain in throat). 6. Khushuna al-Halaq (Irritation in throat).

Exclusion criteria

Exclusion criteria: 1. Patients with all four classic symptoms of Group A Streptococcal pharyngitis: • Pharyngeal or Tonsillar exudates • Swollen anterior cervical nodes • History of fever more than 380 C • Absence of cough 2. Known cases of Renal/ Hepatic/ Cardiac ailments/ Diabetes mellitus 3. Pregnant and lactating women 4. Oral candidiasis 5. Epiglottitis, 6. Herpes Simplex 7. Mononucleosis 8. Gastro esophageal reflux

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms of Waram-i-Halaq (Pharyngitis)Timepoint: 1 WEEK	—

Secondary

Measure	Time frame
Haematological and biochemical assessment for safety assessmentTimepoint: 1 WEEK	—

Countries

India

Contacts

Public ContactDR PRADEEP KUMAR

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@gmail.com9810161758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026